MMSI (Merit Medical Systems) ROCE % : 7.52% (As of Dec. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Merit Medical Systems ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Merit Medical Systems's annualized ROCE % for the quarter that ended in Dec. 2024 was 7.52%.

Merit Medical Systems ROCE % Historical Data

The historical data trend for Merit Medical Systems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems ROCE % Chart

Merit Medical Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-0.21

4.09

6.23

7.16

8.38

Merit Medical Systems Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															7.79	7.95	9.89	8.10	7.52

Merit Medical Systems ROCE % Calculation

Merit Medical Systems's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	181.212	/	( ( (2325.244 - 203.564)	+	(2418.603 - 216.402) )	/ 2 )
	=	181.212	/	( (2121.68	+	2202.201)	/ 2 )
	=	181.212	/	2161.9405
	=	8.38 %

Merit Medical Systems's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	164.552	/	( ( (2378.084 - 201.079)	+	(2418.603 - 216.402) )	/ 2 )
	=	164.552	/	( ( 2177.005	+	2202.201 )	/ 2 )
	=	164.552	/	2189.603
	=	7.52 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Merit Medical Systems (NAS:MMSI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Merit Medical Systems ROCE % Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Merit Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MM3:Germany

Address

1600 West Merit Parkway, South Jordan, UT, USA, 84095

Website

https://www.merit.com

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.

Executives

F. Ann Millner	director	4275 SPRING ROAD, OGDEN UT 84403
Raul Jr. Parra	officer: Interim CFO	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Neil Peterson	officer: Chief Operating Officer	1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Joseph Wright	officer: President, International	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans	director	C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102
Thomas James Gunderson	director	5905 LONG BRAKE TRAIL, EDINA MN 55439
A Scott Anderson	director	ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Michel James Voigt	officer: Chief Human Resources Officer	1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
Fred P Lampropoulos	director, officer: President & CEO
Lynne Ward	director	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Brian G. Lloyd	officer: Chief Legal Officer, Secretary	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost	officer: Chief Operating Officer	1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks	officer: Chief Strategy & Innovation O.	1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Michael R Mcdonnell	director	C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Laura S. Kaiser	director	10101 WOODFIELD LANE, ST. LOUIS MO 63132